FDA Investigator Karen S Anthony
Karen S Anthony has inspections in 8 countries as of 24 Aug 2023. Karen S Anthony has collaborated with a combined 1147 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
24 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland,
Netherlands,
United States of America,
Switzerland,
India,
Italy,
France,
Denmark
Co-Investigator(s):
Alexandria L Capuano,
Andrew F Cohen,
Bapu R Gaddam,
Benjamin J Dastoli,
Brian R Yain,
Brian R Yaun,
Bryan J Love,
Catherine J Laufmann,
Charles D Boison,
Christina K Theodorou,
Christine I Shaw,
Cynthia L Rakestraw,
Dennis L Doupnik,
Dianne H Milazzo,
Dianne T Hamilton,
Dipesh K Shah,
Douglas A Campbell,
Emmanuel A Dimaano, Jr,
Eric Rothschild,
Erica L Nicoll,
Erika V Butler,
Farhana Khan,
Frank J Marciniak,
George T Allen, Jr,
Gerald D Bromley, Jr,
Gerald Mierle,
Graham N Giesen,
Heath A Gerber,
James M Odonnell,
Jane R Donnelly,
Janet B Abt,
Jocelyn E Massey,
Joey C West,
Jose R Hernandez,
Joseph R Hatcher,
Katherine Szestypalow,
Kham Phommachanh,
Laureen M Geniusz,
LCDR Wilfred A Darang,
LCDR William H Bender,
Lori J Silverstein,
LTJG Bradley E Benasutti,
Margaret Torres Vazquez,
Mary K Leslie,
Mary R Kirker,
Michael J Nerz,
Minh D Phan,
Nancy L Meade,
Nicole E Knowlton,
Phillip M Pontikos,
Richard L Rutherford,
Rita K Kabaso,
Robert J Doyle,
Rodney D Combs,
Sherry L Secrist, BLT DO,
State Agency,
Stephen C Eason,
Steven P Donald,
Tammy M Phillips,
Teresa Jimenez,
Tiffani D Wilson,
Tiki J Dixon,
Travis R Hunt,
Victor Spanioli
Karen S Anthony's Documents
Publish Date | Document Type | Title |
---|---|---|
September, 2013 | FDA 483 | Fortitech Europe Aps - Form 483, 2013-09-17 |
September, 2004 | EIR | LifeNet - EIR, 2004-10-11 |
April, 2004 | EIR | Apitoria Pharma Private Limited - EIR, 2004-06-14 |
September, 2013 | EIR | Fortitech Europe Aps - EIR, 2013-09-17 |
March, 2003 | FDA 483 | Old Dominion Eye Foundation, Inc. - Form 483, 2003-03-07 |
March, 2003 | FDA 483 Response | Old Dominion Eye Foundation, Inc. - Form 483R, 2003-03-21 |
March, 2003 | EIR | Old Dominion Eye Foundation, Inc. - EIR, 2003-03-07 |
September, 2018 | EIR | Sonneborn, LLC - EIR, 2018-11-02 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more